by Terry Chrisomalis Valeant Pharmaceuticals Intl Inc On November 18, 2015, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had received approval for two new indications of …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shares are trading down nearly 2% this morning. The biotech company released a Form 8-K yesterday after the close, notifying the …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) soaring 30% in early morning trading, adding to their 20% rise after Friday’s news that the company appointed Martin Shkreli as …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shares are up nearly 20% in pre-market trading this morning after the company announced that investor group comprised of Martin …
KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), announced that an investor group led by Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shares skyrocketed more than 400% today after Turing Pharmaceuticals founder Martin Shkreli disclosed that he has purchased 1.2 million shares of the …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) announced that it has been informed that an investor group comprised of Martin Shkreli and associates together have acquired …
By Terry Chrisomalis Anavex Life Sciences Corp On November 9, 2015 Anavex Life Sciences Corp. (NASDAQ:AVXL) reported positive phase 2a results for the …
KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) announced that it will wind down its operations and that it has engaged the Brenner Group to lead those …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) announced that it will reduce its workforce as part of a plan to reduce operating costs. This action will …
